HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Adenoviral expression of protein-L-isoaspartyl methyltransferase (PIMT) partially attenuates the biochemical changes in PIMT-deficient mice.

Abstract
Protein-L-isoaspartyl methyltransferase (PIMT) is a putative protein repair enzyme, which methylates the alpha-carboxyl group of atypical L-isoaspartyl residues in aged proteins and converts them to normal L-aspartyl residues. Two splicing variants, PIMT-I and PIMT-II, have been reported, although their biological functions and specific subcellular substrates are still to be defined. We and another group have previously showed that PIMT-deficient mice succumbed to fatal epileptic seizures associated with an abnormal accumulation of isoaspartate (IsoAsp) in the brain. In the present study, we prepared two recombinant adenovirus vectors that contained PIMT-I or PIMT-II, respectively, in order to investigate the differential biological roles of PIMT-I and PIMT-II. These recombinant viruses differentially conferred PIMT-I or PIMT-II expressions in cultured neurons. Biochemical analyses showed that either of PIMT-I or PIMT-II effectively repaired the damaged proteins in PIMT-deficient neurons, but the concomitant expression failed to show an additive effect in the repair of IsoAsp. These results suggested that PIMT-I and PIMT-II might share a common biological function and/or subcellular substrates. In addition, we administered an adeno-PIMT-I vector into the brain of PIMT-deficient mice at embryonic day 14.5 by an exo-utero method to assess the biological effects in vivo. The result showed that recombinant adeno-PIMT improved the symptoms of PIMT-deficient mice in vivo, but only partially repaired IsoAsp in damaged proteins. The gene therapy presented in this report provided a better prognosis for the survival of PIMT-deficient mice than the previously reported anti-epileptic drug therapy. The results suggested a new reagent for gene therapy applicable to ageing-associated neurodegenerative disorders.
AuthorsMidori Ogawara, Mayumi Takahashi, Takahiko Shimizu, Mitsunari Nakajima, Yasuhiro Setoguchi, Takuji Shirasawa
JournalJournal of neuroscience research (J Neurosci Res) Vol. 69 Issue 3 Pg. 353-61 (Aug 1 2002) ISSN: 0360-4012 [Print] United States
PMID12125076 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2002 Wiley-Liss, Inc.
Chemical References
  • Isoenzymes
  • Recombinant Proteins
  • Protein D-Aspartate-L-Isoaspartate Methyltransferase
Topics
  • Adenoviridae
  • Animals
  • Blotting, Western
  • Brain (embryology, enzymology)
  • Cell Culture Techniques
  • Epilepsy (enzymology, genetics)
  • Fibroblasts
  • Genetic Therapy (methods)
  • Genetic Vectors
  • Hippocampus (enzymology)
  • Immunohistochemistry
  • Isoenzymes
  • Mice
  • Mice, Transgenic
  • Neurons (enzymology)
  • Protein D-Aspartate-L-Isoaspartate Methyltransferase (deficiency, genetics, metabolism, therapeutic use)
  • Recombinant Proteins (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: